ABEO Abeona Therapeutics Inc

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.

As of 07/01/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  09/19/1980
Outstanding shares:  146,949,529
Average volume:  1,835,852
Market cap:   $30,565,502
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYNS0T7
Valuation   (See tab for details)
PE ratio:   -0.42
PB ratio:   0.90
PS ratio:   9.13
Return on equity:   -285.36%
Net income %:   -2,681.56%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy